Information Links
Mims
Main Navigation
Drugs
Conditions
ArticlesNew drugs
Two new steroid inhalers launched
A new beclometasone metered-dose inhaler and a new...
NICE approves new diabetes treatment for NHS prescribing
Ertugliflozin (Steglatro), the newest sodium glucose...
New contraceptive vaginal ring launched
SyreniRing (ethinylestradiol/etonogestrel) is a contraceptive...
First topical treatment for premature ejaculation now available on prescription
Fortacin is the first topical treatment approved for...
New non-hormonal menopause treatment
Prescribers treating postmenopausal women with vulvar...
New injection allows weekly or monthly treatment of opioid dependence
Buvidal (buprenorphine) is licensed for the treatment...
Launch of new SGLT2 inhibitor increases choice in diabetes prescribing
Ertugliflozin (Steglatro) is a sodium glucose co-transporter...
New once-weekly GLP-1 agonist for diabetes
Ozempic (semaglutide) is a glucagon-like peptide-1...
New salmeterol/fluticasone breath-actuated inhaler for asthma and COPD
Fusacomb Easyhaler (salmeterol/fluticasone) is a new...
New atypical antipsychotic offers potential benefits in treatment of schizophrenia
Reagila (cariprazine) is an orally active partial agonist...
MIMS Clinics
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
